FindTrial
Sign In

The use of polyherbal tea as intervention in the management of metabolic syndrome in type 2 diabetes/hypertensive patients in a health facility in Ashanti region of Ghana: A randomized controlled trial

The use of polyherbal tea as intervention in the management of metabolic syndrome in type 2 diabetes/hypertensive patients in a health facility in Ashanti region of Ghana: A randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202607636659381
Enrollment
40
Registered
2026-07-21
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

no placebo treatment
formulated polyherbal tea

Sponsors

RITA ESI JONES DANSO YEBOAH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients suffering from type 2 diabetes or hypertension and are between the ages 21 and 75 years will be included

Exclusion criteria

Exclusion criteria: Patients suffering from type 2 diabetes or hypertension and are below 21 years and above 75 years will be encluded

Design outcomes

Primary

MeasureTime frame
It is expected that the effectiveness of the polyherbal tea on metabolic syndrome in participants on normal medication as compared to control group on medication only will be established.—

Secondary

MeasureTime frame
It is expected that the safety assessment (acute toxicity test, liver test, kidney test, glycaemic test and lipid profile test) of tea on rats will be determined—

Countries

Ghana

Contacts

Public ContactCHRISTOPHER LARBIE

MAIN SUPERVISOR

ekowlarbie@gmail.com+233243445961

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026